Tilray CEO discusses cannabis company’s recent deal with Novartis

Tilray CEO Brendan Kennedy joins “Power Lunch” to discuss his company’s recent deal with Novartis to improve its distribution network.


  1. So much hate towards Tilray – and all they do (the company) is score big and win. They are they Yankees to baseball, Patriots to football. This deal is so big that I don't even think investors understand just how big it is. Establishing yourself in the medical space versus the recreational space is so huge and nobody will be able to pull them down. Recreational – have at it. Tilray as a company makes no bad moves.

Leave a Reply

Your email address will not be published.